← Leaderboards
Michael M. Graham
University Of Washington
$2,048,791
Attributed
$6,400,373
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $655.2K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,552,313 · 8
AHRQ$48,060 · 1
By mechanism
U01$5,802,110 · 1
P20$1,200,000 · 3
R01$488,418 · 1
R13$48,060 · 1
P30$38,291 · 2
P41$23,494 · 1
Top collaborators
- John M Buatti10 shared
- Thomas L. Casavant10 shared
- Milan Sonka10 shared
Most similar at University Of Washington
Same institution · by research overlap
- Katharine Anthony Bradley$17,650,205
- Farhood Farjah$5,283,632
- Eric B Larson$50,741,279
- Paul E. M. Phillips$15,934,032
- Peter Tarczy-Hornoch$19,484,298
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingCollaborationsDatabasesFundingResponseImageIowaTumorCancer TherapyCancer ImagingUniversitiesPositron-Emission TomographyImage AnalysisImage Archival SystemBaseHead And Neck CancerMalignant NeoplasmsOncologyEngineeringData SetDecision MakingFutureCalibrationBioinformatics
Grant awards (25)
Quantitative Imaging to Assess Response in Cancer Therapy Trials$603,792
U01 · FY2019 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$622,467
U01 · FY2018 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$622,467
U01 · FY2017 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$622,467
U01 · FY2016 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$617,490
U01 · FY2015 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$501,587
U01 · FY2014 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$499,351
U01 · FY2013 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$545,255
U01 · FY2012 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$560,046
U01 · FY2011 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$607,188
U01 · FY2010 · CA
To develop a plan for molecular imaging comparative effectiveness research$48,060
R13 · FY2010 · HS · contact PI
Tumor Imaging$22,489
P30 · FY2009 · CA · contact PI
TUMOR IMAGING$15,802
P30 · FY2005 · CA
Molecular Imaging of Responses to Cancer Therapy$400,000
P20 · FY2003 · CA
Molecular Imaging of Responses to Cancer Therapy$400,000
P20 · FY2002 · CA
METABOLIC IMAGING OF CANCER (CORE C ANALYSIS)$0
P41 · FY2002 · RR
CORE--BIOSTATISTICS$0
P20 · FY2002 · CA
EARLY ASSESSMENT OF THERAPEUTIC RESPONSE IN LYMPHOMAS$0
P20 · FY2002 · CA
Molecular Imaging of Responses to Cancer Therapy$400,000
P20 · FY2001 · CA
FDG PET IMAGING OF COLON CARCINOMA RESPONSE TO THERAPY$250,543
R01 · FY2001 · CA
METABOLIC IMAGING OF CANCER (CORE C ANALYSIS)$0
P41 · FY2001 · RR
CORE--BIOSTATISTICS$0
P20 · FY2001 · CA
EARLY ASSESSMENT OF THERAPEUTIC RESPONSE IN LYMPHOMAS$0
P20 · FY2001 · CA
FDG PET IMAGING OF COLON CARCINOMA RESPONSE TO THERAPY$237,875
R01 · FY2000 · CA
METABOLIC IMAGING OF CANCER (CORE C ANALYSIS)$23,494
P41 · FY2000 · RR